Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Backus, H. H. J.
Right arrow Articles by Peters, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Backus, H. H. J.
Right arrow Articles by Peters, G. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 12:209-216, 2001
© 2001 European Society for Medical Oncology


research-article

5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients

H. H. J. Backus1, D. F. Dukers2, C. J. van Groeningen1, W. Vos2, E. Bloemena2, D. Wouters1, J. M. G. H. van Reil1, K. Smid1, G. Giaccone1, H. M. Pinedo1 and G. J. Peters1,

1Departments of Medical Oncology Amsterdam. The Netherlands
2Departments of Pathology, University Hospital Vrije Universiteit Amsterdam. The Netherlands

Department of Medical Oncology University Hospital Vrije Universiteit De Boelelaan 1117 1081 HV Amsterdam The Netherlands gj.peters{at}azvu.nl

BACKGROUND:: In vitro, thymidylate synthase (TS) inhibition by 5-fluorouracil (5-FU) induces thymineless apoptosis possibly via Fas receptor–Fas ligand interactions and cell-cycle arrest. In colorectal cancer patients we evaluated whether 5-FU administration also resulted in apoptosis and cell-cycle arrest and which proteins might be involved.

PATIENTS AND METHODS:: Patients and methods: Biopsy specimens were taken from 36 patients 2, 22 or 46 hours after administration of 500 mg/m2 5-FU, and from 12 control patients who did not receive 5-FU. In frozen tissue-sections from liver metastases immunohistochemistry was performed with antibodies directed against p53, p21, E2F2, Rb, Ki67 and TS (cell-cycle related) and bax, BCL-2, BCL-x, mcl-1, PARP, caspase-3, Fas receptor and Fas ligand (apoptosis related). Apoptosis was determined by M30 immunostaining, which recognises a cleavage product of cytokeratin 18.

RESULTS:: Fas receptor expression was 50% higher (P = 0.036) 46 hours after 5-FU administration compared to the control group. This was associated with a 12% increase (P < 0.02) in M30 positive tumour cells and with elevation of caspase-3 and PARP expression. The expression of Ki67 and E2F2 was 30% lower after 46 hours compared to the control group, whereas TS was 56% lower after 2 hours and 32% higher again after 46 hours. No differences in the expression of the other proteins were found.

CONCLUSIONS:: These results suggest that 5-FU decreases proliferation status and induces apoptosis possibly via the Fas pathway. Since Fas mediated cell killing is important for cytotoxic T cells this indicates that clinical studies combining immunotherapy for activation of T cells and chemotherapy using 5-FU might be very effective.

apoptosis, cell-cycle arrest, colorectal cancer, Fas, 5-fluorouracil, thymidylate synthase


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
P. K. Wu, W. M. Chen, C. F. Chen, O. K. Lee, C. K. Haung, and T. H. Chen
Primary Osteogenic Sarcoma with Pulmonary Metastasis: Clinical Results and Prognostic Factors in 91 Patients
Jpn. J. Clin. Oncol., August 1, 2009; 39(8): 514 - 522.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Duan, Z. Zhou, S.-F. Jia, M. Colvin, E. A. Lafleur, and E. S. Kleinerman
Interleukin-12 Enhances the Sensitivity of Human Osteosarcoma Cells to 4-Hydroperoxycyclophosphamide by a Mechanism Involving the Fas/Fas-Ligand Pathway
Clin. Cancer Res., January 15, 2004; 10(2): 777 - 783.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
H H J Backus, C J Van Groeningen, W Vos, D F Dukers, E Bloemena, D Wouters, H M Pinedo, and G J Peters
Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases
J. Clin. Pathol., March 1, 2002; 55(3): 206 - 211.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Zhang, G. C. Prendergast, and R. G. Fenton
Farnesyltransferase Inhibitors Reverse Ras-mediated Inhibition of Fas Gene Expression
Cancer Res., January 1, 2002; 62(2): 450 - 458.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.